Venture capital is in the middle of a quiet power shift.
Over the past few years, some of the largest and most consequential deals in tech, healthcare and life sciences have not been led by traditional venture firms at all. Instead, family offices and sovereign wealth funds are backing bigger bets, longer timelines and platforms that stretch across borders, often outside the constraints of the traditional 10-year fund model. READ MORE